Company Analysis Hisamitsu Pharmaceutical Co., Inc.
1. Summary
Advantages
- The stock's return over the last year (10.29%) is higher than the sector average (6.13%).
- The company's current efficiency (ROE=5.36%) is higher than the sector average (ROE=1.13%)
Disadvantages
- Price (4164 Β₯) is higher than fair price (2002.4 Β₯)
- Dividends (2.61%) are below the sector average (2.87%).
- Current debt level 0.6387% has increased over 5 years from 0.6353%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Hisamitsu Pharmaceutical Co., Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -1.3% | 0% | 0.2% |
| 90 days | -5.7% | 6.1% | 2.1% |
| 1 year | 10.3% | 6.1% | -2.3% |
4530 vs Sector: Hisamitsu Pharmaceutical Co., Inc. has outperformed the "Healthcare" sector by 4.16% over the past year.
4530 vs Market: Hisamitsu Pharmaceutical Co., Inc. has outperformed the market by 12.58% over the past year.
Stable price: 4530 is not significantly more volatile than the rest of the market on "Tokyo Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 4530 with weekly volatility of 0.1979% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (4164 Β₯) is higher than the fair price (2002.4 Β₯).
Price is higher than fair: The current price (4164 Β₯) is 51.9% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (22.03) is lower than that of the sector as a whole (112.46).
P/E vs Market: The company's P/E (22.03) is lower than that of the market as a whole (138.33).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.15) is lower than that of the sector as a whole (70.29).
P/BV vs Market: The company's P/BV (1.15) is lower than that of the market as a whole (107.9).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.17) is lower than that of the sector as a whole (75.53).
P/S vs Market: The company's P/S indicator (2.17) is lower than that of the market as a whole (108.73).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (8.1) is lower than that of the sector as a whole (29.26).
EV/Ebitda vs Market: The company's EV/Ebitda (8.1) is lower than that of the market as a whole (109.28).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -5.05% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-5.05%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-1.09%).
5.4. ROE
ROE vs Sector: The company's ROE (5.36%) is higher than that of the sector as a whole (1.13%).
ROE vs Market: The company's ROE (5.36%) is lower than that of the market as a whole (9.37%).
5.5. ROA
ROA vs Sector: The company's ROA (4.35%) is higher than that of the sector as a whole (0.6587%).
ROA vs Market: The company's ROA (4.35%) is lower than that of the market as a whole (4.45%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (7.08%) is lower than that of the sector as a whole (9.07%).
ROIC vs Market: The company's ROIC (7.08%) is lower than that of the market as a whole (8.75%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 2.61% is below the average for the sector '2.87%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 2.61% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 2.61% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (47.09%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
